Axillary Lymph Node Metastasis in Patients of Ductal Carcinoma in Situ or Ductal Carcinoma in Situ with Microinvasion.
10.4048/jkbcs.2004.7.3.180
- Author:
Gil Soo SON
1
;
Tae Hyoung KIM
;
Jun Won UM
;
Jae Bock LEE
;
Jeoung Won BAE
;
Bum Hwan KOO
Author Information
1. Department of Surgery, Korea University College of Medicine, Seoul, Korea. kujwbae@unitel.co.kr
- Publication Type:Original Article
- Keywords:
Lymph node metastasis;
Ductal carcinoma in situ;
Microinvasion;
Breast
- MeSH:
Academic Medical Centers;
Breast;
Breast Neoplasms;
Carcinoma, Ductal*;
Carcinoma, Intraductal, Noninfiltrating*;
Humans;
Incidence;
Korea;
Lymph Node Excision;
Lymph Nodes*;
Mass Screening;
Medical Records;
Neoplasm Metastasis*;
Prognosis
- From:Journal of Korean Breast Cancer Society
2004;7(3):180-184
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: The development of publicized screening methods for breast carcinoma detection has led to a marked increase in the discovery of ductal carcinoma in situ (DCIS) or DCIS with microinvasion (DCIS-MI). Axillary lymph node status has been believed to be not only an indicator of prognosis, but also a direction of adjuvant therapy. But the incidence of axillary metastasis in DCIS or DCIS-MI has diversely found in from 0% to 20%. This study was performed to analyze the incidence of axillary metastasis and the predictive factors associated with axillary lymph node metastasis in DCIS or DCIS-MI. METHODS: Patients with DCIS or DCIS-MI and axillary lymph node dissection from 1987 to 2004 were selected from Korea University Medical Center. We reviewed their medical records for age, palpability and size of the tumor, histolgic subtype, nuclear grade, hormone receptor status, and pathologic slides. RESULTS: Fifty two patients in DCIS and Thirty eight patients in DCIS-MI were included in the study. Axillary lymph node metastases were identified in 2 patients (3.8%) in DCIS and 4 patients (10.5%) in DCIS-MI. Tumor size and nuclear grade in DCIS had a borderline significance in association with microinvasion. We could not be able to find any predictive factor associated with axillary lymph node metastasis in DCIS and DCIS-MI. CONCLUSION: Axillary lymph node metastasis in DCIS or DCIS-MI appeared to be not low and there was no predictive factor associated with axillary lymph node metastasis in DCIS and DCIS-MI. But DCIS patients with large tumor size and poor nuclear grade have the high possibility associated with microinvasion, therefore, in that cases, there is a need to consider the possibility of axillary metastasis.
